These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8612115

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD.
    Karpel JP, Kotch A, Zinny M, Pesin J, Alleyne W.
    Chest; 1994 Apr; 105(4):1089-94. PubMed ID: 8162730
    [Abstract] [Full Text] [Related]

  • 23. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.
    Burdet L, de Muralt B, Schutz Y, Fitting JW.
    Thorax; 1997 Feb; 52(2):130-5. PubMed ID: 9059472
    [Abstract] [Full Text] [Related]

  • 24. Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD.
    Martin RJ, Bartelson BL, Smith P, Hudgel DW, Lewis D, Pohl G, Koker P, Souhrada JF.
    Chest; 1999 May; 115(5):1338-45. PubMed ID: 10334150
    [Abstract] [Full Text] [Related]

  • 25. Synergism between ipratropium and theophylline in asthma.
    Kreisman H, Frank H, Wolkove N, Gent M.
    Thorax; 1981 May; 36(5):387-91. PubMed ID: 6458919
    [Abstract] [Full Text] [Related]

  • 26. Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease.
    Mulloy E, McNicholas WT.
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1030-6. PubMed ID: 8214921
    [Abstract] [Full Text] [Related]

  • 27. Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study.
    Alexander MR, Dull WL, Kasik JE.
    JAMA; 1980 Nov 21; 244(20):2286-90. PubMed ID: 7001056
    [Abstract] [Full Text] [Related]

  • 28. Arrhythmogenic effects of combined orally administered theophylline and albuterol in patients with chronic obstructive pulmonary disease.
    Cukier A, Vargas FS, Teixeira LR, Grupi CJ, Terra-Filho M, Carvalho-Pinto RM, Light RW.
    Braz J Med Biol Res; 1994 Dec 21; 27(12):2869-77. PubMed ID: 7550007
    [Abstract] [Full Text] [Related]

  • 29. Comparative assessment of enprofylline and theophylline for chronic obstructive airways disease in the elderly.
    Arnold JD, Courtenay-Evans RJ, Whitfield R, O'Reilly JF, Petrie GR, Higgins AJ, Swift CG.
    Respir Med; 1990 May 21; 84(3):211-5. PubMed ID: 2218006
    [Abstract] [Full Text] [Related]

  • 30. A comparison of enprofylline and theophylline in the maintenance therapy of chronic reversible obstructive airway disease.
    Chapman KR, Boucher S, Hyland RH, Day A, Kreisman H, Rivington R, Hodder RV, York EL, Abboud RT, Peters S.
    J Allergy Clin Immunol; 1990 Feb 21; 85(2):514-21. PubMed ID: 2406328
    [Abstract] [Full Text] [Related]

  • 31. The usefulness of theophylline in nonasthmatic airway obstruction.
    Schmidt R, Altschuler S.
    Angiology; 1979 Nov 21; 30(11):744-9. PubMed ID: 389103
    [Abstract] [Full Text] [Related]

  • 32. Isoproterenol challenge during placebo and oral theophylline therapy in chronic obstructive pulmonary disease.
    Dull WL, Alexander MR, Kasik JE.
    Am Rev Respir Dis; 1981 Mar 21; 123(3):340-2. PubMed ID: 7224346
    [Abstract] [Full Text] [Related]

  • 33. Effect of theophylline on exercise performance in patients with severe chronic obstructive pulmonary disease.
    Fink G, Kaye C, Sulkes J, Gabbay U, Spitzer SA.
    Thorax; 1994 Apr 21; 49(4):332-4. PubMed ID: 8202902
    [Abstract] [Full Text] [Related]

  • 34. Effect of therapeutic theophylline levels on the sleep quality and daytime cognitive performance of normal subjects.
    Fitzpatrick MF, Engleman HM, Boellert F, McHardy R, Shapiro CM, Deary IJ, Douglas NJ.
    Am Rev Respir Dis; 1992 Jun 21; 145(6):1355-8. PubMed ID: 1596003
    [Abstract] [Full Text] [Related]

  • 35. Use of the combination product ipratropium and albuterol in chronic obstructive pulmonary disease.
    Crouch MA, Raney CR, Davis K.
    Arch Intern Med; 1999 Jul 12; 159(13):1501-2. PubMed ID: 10399906
    [No Abstract] [Full Text] [Related]

  • 36. Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease.
    Melão F, Nunes JP, Vasconcelos M, Dias P, Almeida PB, Rodrigues R, Pinho T, Madureira A, Maciel MJ.
    Rev Port Cardiol; 2014 Mar 12; 33(3):175.e1-4. PubMed ID: 24680554
    [Abstract] [Full Text] [Related]

  • 37. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.
    McKay SE, Howie CA, Thomson AH, Whiting B, Addis GJ.
    Thorax; 1993 Mar 12; 48(3):227-32. PubMed ID: 8497820
    [Abstract] [Full Text] [Related]

  • 38. Comparative cost-effectiveness analysis of theophylline and ipratropium bromide in chronic obstructive pulmonary disease. A three-center study.
    Jubran A, Gross N, Ramsdell J, Simonian R, Schuttenhelm K, Sax M, Kaniecki DJ, Arnold RJ, Sonnenberg FA.
    Chest; 1993 Mar 12; 103(3):678-84. PubMed ID: 8449051
    [Abstract] [Full Text] [Related]

  • 39. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease.
    Lal D, Manocha S, Ray A, Vijayan VK, Kumar R.
    J Basic Clin Physiol Pharmacol; 2015 Sep 12; 26(5):443-51. PubMed ID: 25894641
    [Abstract] [Full Text] [Related]

  • 40. Bronchodilator therapy in chronic airflow obstruction.
    Niewoehner DE, Leatherman JW.
    Chest; 1984 Aug 12; 86(2):161-2. PubMed ID: 6146498
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.